Beate K. S.
- Country
- Germany
- Department
- Klinik für Innere Medizin III
Research Overview
- A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED/GLA 2022-1)
- Evaluation of Adjuvant Therapy with Capecitabine in Stage II Colon and Rectal Cancer Patients with ctDNA Positivity Post-Resection
- Phase II Evaluation of 5-Fluorouracil, Panitumumab, and Sotorasib in First-Line Treatment of Advanced KRAS G12C Mutated Colorectal Adenocarcinoma
Data & Insights
Has run more than one trial at 43 of 268 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment and research of colorectal cancers, with particular emphasis on stage II colon cancer management and therapeutic approaches.
- Colon Cancer Treatment
- Adjuvant Therapy Development
- Early-Stage Cancer Management
Primary focus includes advancing treatment strategies for gastrointestinal malignancies and investigating innovative approaches in cancer care.
Precision Medicine
Expertise in circulating tumor DNA (ctDNA) analysis and its application in guiding treatment decisions for cancer patients.
- Molecular Biomarker Research
- Personalized Treatment Strategies
- Cancer Surveillance Methods
Specializes in utilizing molecular diagnostics to optimize cancer treatment selection and monitoring.
Clinical Outcomes
Focuses on investigating disease-free survival and treatment outcomes in gastrointestinal cancer patients.
- Survival Analysis
- Post-Surgical Monitoring
- Treatment Response Assessment
Dedicated to improving patient outcomes through evidence-based therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.